Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
PLA2G2E (human)

Overview
PLA2G2E PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. Has a preference for arachidonic-containing phospholipids. Belongs to the phospholipase A2 family. Note: This description may include information from UniProtKB.
Protein type: Lipid Metabolism - alpha-linolenic acid; Phospholipase; Secreted; EC 3.1.1.4; Lipid Metabolism - linoleic acid; Lipid Metabolism - glycerophospholipid; Lipid Metabolism - ether lipid; Secreted, signal peptide; Lipid Metabolism - arachidonic acid
Cellular Component: extracellular region
Molecular Function: phospholipase A2 activity; calcium ion binding
Biological Process: phospholipid metabolic process; glycerophospholipid biosynthetic process; phosphatidic acid biosynthetic process; inflammatory response; lipid catabolic process
Reference #:  Q9NZK7 (UniProtKB)
Alt. Names/Synonyms: GIIE sPLA2; Group IIE secretory phospholipase A2; PA2GE; Phosphatidylcholine 2-acylhydrolase 2E; phospholipase A2, group IIE; PLA2G2E; sPLA2-IIE
Gene Symbols: PLA2G2E
Molecular weight: 15,989 Da
Basal Isoelectric point: 8.61  Predict pI for various phosphorylation states
Select Structure to View Below

PLA2G2E

Protein Structure Not Found.


STRING  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  ENZYME  |  Phospho.ELM  |  Source  |  UCSD-Nature  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 Y127-p LGTYNRKyAHyPNKL
0 1 Y130-p YNRKyAHyPNKLCtG
0 1 T136-p HyPNKLCtGPtPPC_
0 1 T139-p NKLCtGPtPPC____
  mouse

 
Y127 LNTYNRKYAHYPNKL
Y130 YNRKYAHYPNKLCTG
T136 HYPNKLCTGPTPPC_
T139 NKLCTGPTPPC____
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.